1-4 of 4
Hongyan Tong, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FINAL Results of an Phase, Multicenter, Randomied, Controlled OPEN LEVEL Trial: Decitabine Therapy in Patients with Myelodysplastic Syndromes

Zonghong Shao, MD, Hui Liu, Hao Jiang, Hongyan Tong, PhD, Ruixiang Xiang, Linhua Yang, Hongguo Zhao, MD, Jian Ouyang, MD, Hai Bai, Hui Sun, Li Hou, Ming Jiang, Zeng Yun, MD PhD, Zhuogang Liu, Aibin Liang, MD PhD, Yinghua Xie, Kang Yu, MD, Zhimin Zhai, MD, Li Liu
Journal: Blood
Blood (2018) 132 (Supplement 1): 3865.
https://doi.org/10.1182/blood-2018-99-116041
Published: 2018
Journal Articles

The High NRF2 Expression Confers Chemotherapy Resistance through Upregulated DUSP1 in Myelodysplastic Syndromes

Peipei Lin, Yanling Ren, Xinping Zhou, Chen Mei, Chao Hu, Yingwan Luo, Yile Zhou, Xiaomei Yan, Gang Huang, PhD, Hongyan Tong, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2956.
https://doi.org/10.1182/blood.V130.Suppl_1.2956.2956
Published: 2017
Journal Articles

Study on Mechanisms of Telomerase Regulation in Arsenic Trioxide Inducing Apoptosis in Myelodysplasia Cell Line.

Hongyan Tong, PhD, MD, Jie Jin, PhD, MD, Weilai Xu, PhD, Wenbin Qian, PhD, MD, Maofang Lin
Journal: Blood
Blood (2004) 104 (11): 4706.
https://doi.org/10.1182/blood.V104.11.4706.4706
Published: 2004
Journal Articles

Effect of 5-Aza-2′-Deoxycytidine in High-Risk Myelodysplasia Cells in Vitro.

Hongyan Tong, PhD, MD, Maofang Lin, Jie Jin, PhD, MD.
Journal: Blood
Blood (2004) 104 (11): 4707.
https://doi.org/10.1182/blood.V104.11.4707.4707
Published: 2004